Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7WLY

Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)

Summary for 7WLY
Entry DOI10.2210/pdb7wly/pdb
EMDB information32594
DescriptorSpike glycoprotein, Heavy chain of 35B5 Fab, Light chain of 35B5 Fab, ... (5 entities in total)
Functional Keywordsviral protein, immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2
More
Total number of polymer chains7
Total formula weight532669.78
Authors
Wang, X.,Zhu, Y. (deposition date: 2022-01-14, release date: 2022-05-25, Last modification date: 2024-11-13)
Primary citationWang, X.,Chen, X.,Tan, J.,Yue, S.,Zhou, R.,Xu, Y.,Lin, Y.,Yang, Y.,Zhou, Y.,Deng, K.,Chen, Z.,Ye, L.,Zhu, Y.
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.
Cell Host Microbe, 30:887-, 2022
Cited by
PubMed Abstract: The SARS-CoV-2 Omicron variant harbors more than 30 mutations in the spike protein, leading to immune evasion from many therapeutic neutralizing antibodies. We reveal that a receptor-binding domain (RBD)-targeting monoclonal antibody, 35B5, exhibits potent neutralizing efficacy to Omicron. Cryo-electron microscopy structures of the extracellular domain trimer of Omicron spike with 35B5 Fab reveal that Omicron spike exhibits tight trimeric packing and high thermostability, as well as significant antigenic shifts and structural changes, within the RBD, N-terminal domain (NTD), and subdomains 1 and 2. However, these changes do not affect targeting of the invariant 35B5 epitope. 35B5 potently neutralizes SARS-CoV-2 Omicron and other variants by causing significant conformational changes within a conserved N-glycan switch that controls the transition of RBD from the "down" state to the "up" state, which allows recognition of the host entry receptor ACE2. This mode of action and potent neutralizing capacity of 35B5 indicate its potential therapeutic application for SARS-CoV-2.
PubMed: 35436443
DOI: 10.1016/j.chom.2022.03.035
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.4 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon